Pharma Equity Group A/S
PEG.CO · CPH
6/30/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Revenue | – | DKK 0 | DKK 0 | DKK 0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | – | DKK 0 | DKK 0 | DKK 0 |
| Gross Profit | – | DKK 0 | -DKK 0 | -DKK 0 |
| % Margin | – | – | – | – |
| R&D Expenses | – | DKK 3 | DKK 2 | DKK 2 |
| G&A Expenses | – | DKK 1 | DKK 3 | DKK 3 |
| SG&A Expenses | – | DKK 1 | DKK 3 | DKK 3 |
| Sales & Mktg Exp. | – | DKK 0 | DKK 0 | DKK 0 |
| Other Operating Expenses | – | -DKK 0 | DKK 0 | DKK 0 |
| Operating Expenses | – | DKK 4 | DKK 5 | DKK 5 |
| Operating Income | – | -DKK 4 | -DKK 5 | -DKK 5 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | – | -DKK 1 | -DKK 2 | -DKK 1 |
| Pre-Tax Income | – | -DKK 5 | -DKK 7 | -DKK 6 |
| Tax Expense | – | -DKK 0 | -DKK 0 | -DKK 0 |
| Net Income | – | -DKK 5 | -DKK 7 | -DKK 6 |
| % Margin | – | – | – | – |
| EPS | – | -0.006 | -0.006 | -0.006 |
| % Growth | – | 0% | -5.3% | – |
| EPS Diluted | – | -0.006 | -0.006 | -0.006 |
| Weighted Avg Shares Out | – | 1,023 | 1,023 | 1,023 |
| Weighted Avg Shares Out Dil | – | 1,023 | 1,023 | 1,023 |
| Supplemental Information | – | – | – | – |
| Interest Income | – | DKK 0 | DKK 0 | DKK 0 |
| Interest Expense | – | DKK 1 | DKK 2 | DKK 1 |
| Depreciation & Amortization | – | -DKK 0 | DKK 0 | DKK 0 |
| EBITDA | – | -DKK 4 | -DKK 5 | -DKK 5 |
| % Margin | – | – | – | – |